Update on alcohol and viral hepatitis

Journal of Clinical and Translational Hepatology

Volumn 2, Issue 4, 2014, Pages 228-233

  Gitto, Stefano ^a   Vitale, Giovanni ^b   Villa, Erica ^a   Andreone, Pietro ^b  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Alcohol; HBV; HCV

Indexed keywords

EID: 84971341519     PISSN: 22250719     EISSN: 23108819     Source Type: Journal    
DOI: 10.14218/JCTH.2014.00030     Document Type: Review

References (72)

1. www.niaaa.nih.gov/alcohol-health/overview-alcohol-consumption/standard-drink. Accessed September 2014.
2. Suzuki A, Angulo P, Sauver J, Muto A, Okada T, Lindor K. Light to moderate alcohol consumption is associated with lower frequency of hypertransami-nasemia. Am J Gastroenterol 2007;102:1912–1919. doi: 10.1111/j.1572-0241.2007.01274.x.
3. World Health Organization. Prevention and control of viral hepatitis infection: framework for global action. Geneva: WHO, 2012.
4. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol 2014;60: 392–420. doi: 10.1016/j.jhep.2013.11.003.
5. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012;57:167–185.
6. Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, et al. Alcoholic liver disease–pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006;24:1151–1161. doi: 10.1111/j.1365-2036.2006.03110.x.
7. Maher JJ. Alcoholic liver disease. In: Feldman M, Friedman LS, Sleisenger MH, editors. Gastrointestinal and Liver Disease Vol II. Philadelphia: Saunders, 2002:1375–1391. doi: 10.1016/j.jhep.2012.02.010.
8. Cochrane J, Chen H, Conigrave KM, Hao W. Alcohol use in China. Alcohol Alcohol 2003;38:537–542. doi: 10.1093/alcalc/agg111.
9. Mueller S, Millonig G, Seitz HK. Alcoholic liver disease and hepatitis C: a frequently underestimated combination. World J Gastroenterol 2009;15: 3462–3471. doi: 10.3748/wjg.15.3462.
10. Fan JY, Huang TJ, Jane SW, Chen MY. Prevention of Liver Cancer Through the Early Detection of Risk-Related Behavior Among Hepatitis B or C Carriers. Cancer Nurs 2014 May 15.
11. Singal AK, Anand BS. Mechanisms of synergy between alcohol and hepatitis C virus. J Clin Gastroenterology 2007;41:761–772. doi: 10.1097/MCG.0b013e3180381584.
12. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007;13:2436–2441. doi: 10.3748/wjg.v13.i17.2436.
13. Galperim B, Cheinquer H, Stein A, Fonseca A, Lunge V, Ikuta N. Prevalence of hepatitis C virus in alcoholic: patients: role of parenteral risk factors. Arq Gastroenterol 2006;43:81–84. doi: 10.1590/S0004-28032006000200004.
14. Rosman AS, Waraich A, Galvin K, Casiano J, Paronetto F, Lieber CS. Alcoholism is associated with hepatitis C but not hepatitis B in an urban population. Am J Gastroentrol 1996; 91:498–505.
15. Osna NA. Hepatitis C virus and ethanol alter antigen presentation in liver cell s. Worl d J Gastroenterol 2009; 15: 1201–1208. doi: 10.3748/wjg.15.1201.
16. Kharbanda KK, Bardag-Gorce F, Barve S, Molina PE, Osna NA. Impact of altered methylation in cytokine signaling and proteasome function in alcohol and viral mediated diseases. Alcohol Clin Exp Res 2013;37:1–7. doi: 10.1111/j.1530-0277.2012.01840.x.
17. Noh DH, Lee EJ, Kim AY, Lee EM, Min CW, Kang KK, et al. Alcohol Induced Hepatic Degeneration in a Hepatitis C Virus Core Protein Transgenic Mouse Model. Int J Mol Sci 2014;15:4126–4141. doi: 10.3390/ijms15034126.
18. Zhang T, Li Y, Lai JP, Douglas SD, Metzger TS, O’Brien CP, et al. Alcohol potentiates hepatitis C virus replicon expression. Hepatology 2003;38:57– 65. doi: 10.1053/jhep.2003.50295.
19. Trujillo-Murillo K, Alvarez-Martínez O, Garza Rodriguez L, Martínez-Rodríguez H, Bosques-Padilla F, Ramos-Jimenez J, et al. Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity. J Viral Hepat 2007;14:608–617. doi: 10.1111/j.1365-2893.2006.00837.x.
20. McCartney EM, Semendric L, Helbig KJ, Hinze S, Jones B, Weinman SA, et al. Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon. J Infect Dis 2008;198:1766– 1775. doi: 10.1086/593216.
21. Seronello S, Ito C, Wakita T, Choi J. Ethanol enhances hepatitis C virus replication through lipid metabolism and elevated NADH/NAD+. J Biol Chem 2010;285:845–854. doi: 10.1074/jbc.M109.045740.
22. Plumlee CR, Lazaro CA, Fausto N, Polyak SJ. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells. Virol J 2005;2:89. doi: 10.1186/1743-422X-2-89.
23. Choi J, Forman HJ, Ou JH, Lai MM, Seronello S, Nandipati A. Redox modulation of the hepatitis C virus replication complex is calcium dependent. Free Radic Biol Med 2006;41:1488–1498. doi: 10.1016/j.freeradbiomed.2006.08.008.
24. Osna NA, Kharbanda KK, Sun Y, Simpson RL, Poluektova LE, Ganesan M, et al. Ethanol affects hepatitis C pathogenesis: humanized scid Alb-uPA mouse model. Biochem Biophys Res Commun 2014;450:773–776. doi: 10.1016/j.bbrc.2014.06.048.
25. Yoshihara H, Noda K, Kamada T. Interrelationship between alcohol intake, hepatitis C, liver cirrhosis, and hepatocellular carcinoma. Recent Dev Alcohol 1998;14:457–469.
26. Loguercio C, Di Pierro M, Di Marino MP, Federico A, Disalvo D, Crafa E, et al. Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological and pathological aspects. Alcohol Alcohol 2000;35:296–301. doi: 10.1093/alcalc/35.3.296.
27. Khan KN, Yatsuhashi H. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients. Alcohol Alcohol 2000;35:286–295. doi: 10.1093/alcalc/35.3.286.
28. Romero-Gomez M, Grande L, Nogales MC, Fernandez M, Chavez M, Castro M. Intrahepatic hepatitis C virus replication is increased in patients with regular alcohol consumption. Dig Liver Dis 2001;33:698–702. doi: 10.1016/S1590-8658(01)80048-7.
29. Anand BS, Velez M. Influence of chronic alcohol abuse on hepatitis C virus replication. Dig Dis 2000;18:168–171. doi: 10.1159/000051390.
30. Cromie SL, Jenkins PJ, Bowden DS, Dudley FJ. Chronic hepatitis C: effect of alcohol on hepatic activity and viral titre. J Hepatol 1996;25:821–826. doi: 10.1016/S0168-8278(96)80284-4.
31. Anand BS, Thornby J. Alcohol has no effect on hepatitis C virus replication: a meta-analysis. Gut 2005;54:1468–1472. doi: 10.1136/gut.2004.056697.
32. Larkin J, Clayton MM, Liu J, Feitelson MA. Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice. Hepatology 2001;34:792–797. doi: 10.1053/jhep.2001.27565.
33. Nalpas B, Pourcel C, Feldmann G, Housset C, Tiollais P, Brechot C, et al. Chronic alcohol intoxication decreases the serum level of hepatitis B surface antigen in transgenic mice. J Hepatol 1992;15:118–124. doi: 10.1016/0168-8278(92)90022-H.
34. Otani K, Korenaga M, Beard MR, Li K, Qian T, Showalter LA, et al. Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 2005;128:96–107. doi: 10.1053/j.gastro.2004.10.045.
35. Perlemuter G, Letteron P, Carnot F, Zavala F, Pessayre D, Nalpas B, et al. Alcohol and hepatitis C virus core protein additively increase lipid peroxida-tion and synergistically trigger hepatic cytokine expression in a transgenic mouse model. J Hepatol 2003;39:1020–1027. doi: 10.1016/S0168-8278(03)00414-8.
36. Rigamonti C, Mottaran E, Reale E, Rolla R, Cipriani V, Capelli F, et al. Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C. Hepatology 2003;38:42–49. doi: 10.1053/jhep.2003.50275.
37. Min BY, Kim NY, Jang ES, Shin CM, Lee SH, Park YS, et al. Ethanol potentiates hepatitis B virus replication through oxidative stress-dependent and-independent transcriptional activation. Biochem Biophys Res Commun 2013;431:92–97. doi: 10.1016/j.bbrc.2012.12.081.
38. Mas VR, Fassnacht R, Archer KJ, Maluf D. Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med 2010;16:287–297. doi: 10.2119/molmed.2009.00165.
39. Aloman C, Gehring S, Wintermeyer P, Kuzushita N, Wands JR. Chronic ethanol consumption impairs cellular immune responses against HCV NS5 protein due to dendritic cell dysfunction. Gastroenterology 2007;132:698– 708. doi: 10.1053/j.gastro.2006.11.016.
40. Piasecki BA, Lewis JD, Reddy KR, Bellamy SL, Porter SB, Weinrieb RM, et al. Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 2004;40:892–899. doi: 10.1002/hep.1840400419.
41. Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, et al. Alcoholic liver disease – pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006;24:1151–1161. doi: 10.1111/j.1365-2036.2006.03110.x.
42. Zarski JP, Mc Hutchison J, Bronowicki JP, Sturm N, Garcia-Kennedy R, Hodaj E, et al. Rate of natural disease progression in patients with chronic hepatitis C. J Hepatol 2003;38:307–314. doi: 10.1016/S0168-8278(02)00387-2.
43. Tsui JI, Pletcher MJ, Vittinghoff E, Seal K, Gonzales R. Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. J Hepatol 2006;44:262–266. doi: 10.1016/j.jhep.2005.07.027.
44. Singal AK, Kuo YF, Anand BS. Hepatitis C virus infection in alcoholic hepatitis: prevalence patterns and impact on in-hospital mortality. Eur J Gastroenterol Hepatol 2012;24:1178–1184. doi: 10.1097/MEG.0b013e328355cce0.
45. Fuster D, Sanvisens A, Bolao F, Serra I, Rivas I, Tor J, et al. Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients. J Viral Hepat 2014 Aug 18. doi: 10.1111/jvh.12290.
46. Hutchinson SJ, Bird SM, Goldberg DJ. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 2005;3:1150–1159. doi: 10.1016/S1542-3565(05)00407-6.
47. Larkin J, Clayton MM, Liu J, Feitelson MA. Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice. Hepatology 2001;34:792–797. doi: 10.1053/jhep.2001.27565.
48. Ong A, Wong VW, Wong GL, Chan HL. The effect of caffeine and alcohol consumption on liver fibrosis-a study of 1045 Asian hepatitis B patients using transient elastography. Liver Int 2011;31:1047–1053. doi: 10.1111/j.1478-3231.2011.02555.x.
49. Marcellin P, Pequignot F, Delarocque-Astagneau E, Zarski JP, Ganne N, Hillon P, et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol 2008;48:200–207. doi: 10.1016/j.jhep.2007.09.010.
50. Zhang M. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis. Alcohol 2013;47: 553–558. doi: 10.1016/j.alcohol.2013.07.003.
51. Fukushima W, Tanaka T, Ohfuji S, Habu D, Tamori A, Kawada N, et al. Does alcohol increase the risk of hepatocellular carcinoma among patients with hepatitis C virus infection? Hepatol Res 2006;34:141–149. doi: 10.1016/j.hepres.2005.12.003.
52. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206–1213. doi: 10.1053/jhep.2002.36780.
53. Tsutsumi M, Ishizaki M, Takada A. Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: A multiple logistic-regression coefficient analysis. Alcohol Clin Exp Res 1996;20:758– 762. doi: 10.1111/j.1530-0277.1996.tb01683.x.
54. Loomba R, Yang HI, Su J, Brenner D, Iloeje U, Chen CJ. Obesity and alcohol synergize to increase the risk of incident hepatocellular carcinoma in men. Clin Gastroenterol Hepatol 2010;8:891–898. doi: 10.1016/j.cgh.2010.06.027.
55. Yamada M, Shiroeda H, Hayashi R, Yano H, Sato K, Tsutsumi M, et al. Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol. J Clin Biochem Nutr 2011;48:167–169. doi: 10.3164/jcbn.09-119GFR.
56. Kubo S, Kinoshita H, Hirohashi K, Tanaka H, Tsukamoto T, Shuto T, et al. High malignancy of hepatocellular carcinoma in alcoholic patients with hepatitis C virus. Surgery 1997;121:425–429. doi: 10.1016/S0039-6060(97)90313-5.
57. Okada S, Ishii H, Nose H, Okusaka T, Kyogoku A, Yoshimori M, et al. Effect of heavy alcohol intake on long-term results after curative resection of hepatitis C virus related hepatocellular carcinoma. Jpn J Cancer Res 1996;87:867– 873.
58. Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen-and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcohol Clin Exp Res 2003;27(8 Suppl):47S–51S. doi: 10.1097/01.ALC.0000079449.47468.B0.
59. Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Scand J Gastroenterol 2008;43:849–856.
60. Mochida S, Ohnishi K, Matsuo S, Kakihara K, Fujiwara K. Effect of alcohol intake on the efficacy of interferon therapy in patients with chronic hepatitis C as evaluated by multivariate logistic regression analysis. Alcohol Clin Exp Res 1996;20:371–377. doi: 10.1111/j.1530-0277.1996.tb01811.x.
61. Di Bona D, Cippitelli M, Fionda C, Cammà C, Licata A, Santoni A, et al. Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. J Hepatol 2006;45:271–279. doi: 10.1016/j.jhep.2006.01.037.
62. Ohnishi K, Matsuo S, Matsutani K, Itahashi M, Kakihara K, Suzuki K, et al. Interferon therapy for chronic hepatitis C in habitual drinkers: comparison with chronic hepatitis C in infrequent drinkers. Am J Gastroenterol 1996;91: 1374–1379.
63. Bruggmann P, Dampz M, Gerlach T, Kravecz L, Falcato L. Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss Hepatitis C Cohort Study. Drug Alcohol Depend 2010;110:167– 171. doi: 10.1016/j.drugalcdep.2010.02.016.
64. Anand BS, Currie S, Dieperink E, Bini EJ, Shen H, Ho SB, et al. Alcohol use and treatment of hepatitis C virus: results of a national multicenter study. Gastroenterology 2006; 130:1607–1616. doi: 10.1053/j.gastro. 2006.02.023.
65. Le Lan C, Guillygomarch A, Danielou H, Le Dreau G, Lainé F, Vedeilhié C, et al. A multi-disciplinary approach to treating hepatitis C with interferon and ribavirin in alcohol-dependent patients with ongoing abuse. J Hepatol 2012; 56:334–340. doi: 10.1016/j.jhep.2011.05.021.
66. Lin CC. Hepatitis C treatment outcome in relation to alcohol consumption and racial differences in southeastern Taiwan. J Formos Med Assoc 2014 Apr 21. doi: 10.1016/j.jfma.2014.03.001.
67. North CS, Sims O, Hong BA, Jain MK, Brown G, Lisker-Melman M, et al. An empirical study of alcohol consumption by patients considering HCV treatment. Am J Drug Alcohol Abuse 2014;40:484–489. doi: 10.3109/00952990.2014.945592.
68. Dieperink E, Fuller B, Isenhart C, McMaken K, Lenox R, Pocha C, et al. Efficacy of motivational enhancement therapy on alcohol use disorders in patients with chronic hepatitis C: a randomized controlled trial. Addiction 2014;109:1869–1877. doi: 10.1111/add.12679.
69. Chung WG, Kim HJ, Choe YG, Seok HS, Chon CW, Cho YK, et al. Effect of alcohol and obesity on entecavir therapy. Clin Mol Hepatol 2012;18:195– 202. doi: 10.3350/cmh.2012.18.2.195.
70. Spradling PR, Bulkow L, Teshale EH, Negus S, Homan C, Simons B, et al. Prevalence and causes of elevated serum aminotransferase levels in a population-based cohort of persons with chronic hepatitis B virus infection. J Hepatol 2014 Jun 6.
71. Papatheodoridis GV, Tsochatzis E, Hardtke S, Wedemeyer H. Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review. Liver Int 2014;34:1452–1463. doi: 10.1111/liv.12565.
72. Antonucci G, Mazzotta F, Puoti M, Angeletti C, Girardi E, Santantonio T, et al. Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy. J Viral Hepat 2012;19:881–889. doi: 10.1111/j.1365-2893.2012.01615.x.